BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8246286)

  • 1. K-ras mutations in putative preneoplastic lesions in human colon.
    Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
    J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
    Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S
    Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
    Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
    Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras oncogene mRNA and protein in aberrant crypt foci.
    Stopera SA; Bird RP
    Carcinogenesis; 1992 Oct; 13(10):1863-8. PubMed ID: 1423846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
    Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
    Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer.
    Stopera SA; Murphy LC; Bird RP
    Carcinogenesis; 1992 Nov; 13(11):2081-5. PubMed ID: 1423879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
    Yuan P; Sun M; Zhang J; Zhu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane.
    Davies MJ; Rumsby PC
    Teratog Carcinog Mutagen; 1998; 18(4):183-97. PubMed ID: 9804274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
    Hu Y; Le Leu RK; Young GP
    Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis?
    Pretlow TP
    Gastroenterology; 1995 Feb; 108(2):600-3. PubMed ID: 7835604
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa.
    Jacoby RF; Llor X; Teng BB; Davidson NO; Brasitus TA
    J Clin Invest; 1991 Feb; 87(2):624-30. PubMed ID: 1991846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
    Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
    N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine.
    Femia AP; Tarquini E; Salvadori M; Ferri S; Giannini A; Dolara P; Caderni G
    Int J Cancer; 2008 Jan; 122(1):117-23. PubMed ID: 17847023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in aberrant crypt foci from human colons.
    Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
    Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
    Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
    Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras and p53 mutations in human colorectal aberrant crypt foci.
    Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
    J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.
    Calcagno SR; Li S; Colon M; Kreinest PA; Thompson EA; Fields AP; Murray NR
    Int J Cancer; 2008 Jun; 122(11):2462-70. PubMed ID: 18271008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression?
    Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
    Cancer; 1995 Mar; 75(6 Suppl):1527-33. PubMed ID: 7889486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer.
    Konstantakos AK; Siu IM; Pretlow TG; Stellato TA; Pretlow TP
    Gastroenterology; 1996 Sep; 111(3):772-7. PubMed ID: 8780584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.